Sixty years old is the breakpoint of human frontal cortex aging
Human brain aging is the physiological process which underlies as cause of cognitive decline in the elderly and the main risk factor for neurodegenerative diseases such as Alzheimer's disease. Human neurons are functional throughout a healthy adult lifespan, yet the mechanisms that maintain fun...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión aceptada para publicación |
| Fecha de publicación: | 2017 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/140516 |
| Acceso en línea: | https://hdl.handle.net/2445/140516 |
| Access Level: | acceso abierto |
| Palabra clave: | Envelliment Lòbul frontal Metabolisme Aging Frontal lobe Metabolism |
| id |
ES_ce0d46cc1b5b976b4f468e8b9deee7f2 |
|---|---|
| oai_identifier_str |
oai:recercat.cat:2445/140516 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Sixty years old is the breakpoint of human frontal cortex agingCabré, RosannaNaudi, AlbaDomínguez González, MayelínAyala, VictòriaJove, MarionaMota-Martorell, NataliaPiñol Ripoll, GerardGil-Villar, Maria PilarRué, MontserratPortero-Otin, ManuelFerrer, Isidro (Ferrer Abizanda)Pamplona, ReinaldEnvellimentLòbul frontalMetabolismeAgingFrontal lobeMetabolismHuman brain aging is the physiological process which underlies as cause of cognitive decline in the elderly and the main risk factor for neurodegenerative diseases such as Alzheimer's disease. Human neurons are functional throughout a healthy adult lifespan, yet the mechanisms that maintain function and protect against neurodegenerative processes during aging are unknown. Here we show that protein oxidative and glycoxidative damage significantly increases during human brain aging, with a breakpoint at 60 years old. This trajectory is coincident with a decrease in the content of the mitochondrial respiratory chain complex I to IV. We suggest that the deterioration in oxidative stress homeostasis during aging induces an adaptive response of stress resistance mechanisms based on the sustained expression of REST, and increased or decreased expression of Akt and mTOR, respectively, over the adult lifespan in order to preserve cell neural survival and function.Elsevier B.V.2019201920172019info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersion9 p.application/pdfhttps://hdl.handle.net/2445/140516Articles publicats en revistes (Patologia i Terapèutica Experimental)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésVersió postprint del document publicat a: https://doi.org/10.1016/j.freeradbiomed.2016.12.010Free Radical Biology and Medicine, 2017, vol. 103, p. 14-22https://doi.org/10.1016/j.freeradbiomed.2016.12.010cc-by-nc-nd (c) Elsevier B.V., 2017http://creativecommons.org/licenses/by-nc-nd/3.0/esinfo:eu-repo/semantics/openAccessoai:recercat.cat:2445/1405162026-05-29T05:05:01Z |
| dc.title.none.fl_str_mv |
Sixty years old is the breakpoint of human frontal cortex aging |
| title |
Sixty years old is the breakpoint of human frontal cortex aging |
| spellingShingle |
Sixty years old is the breakpoint of human frontal cortex aging Cabré, Rosanna Envelliment Lòbul frontal Metabolisme Aging Frontal lobe Metabolism |
| title_short |
Sixty years old is the breakpoint of human frontal cortex aging |
| title_full |
Sixty years old is the breakpoint of human frontal cortex aging |
| title_fullStr |
Sixty years old is the breakpoint of human frontal cortex aging |
| title_full_unstemmed |
Sixty years old is the breakpoint of human frontal cortex aging |
| title_sort |
Sixty years old is the breakpoint of human frontal cortex aging |
| dc.creator.none.fl_str_mv |
Cabré, Rosanna Naudi, Alba Domínguez González, Mayelín Ayala, Victòria Jove, Mariona Mota-Martorell, Natalia Piñol Ripoll, Gerard Gil-Villar, Maria Pilar Rué, Montserrat Portero-Otin, Manuel Ferrer, Isidro (Ferrer Abizanda) Pamplona, Reinald |
| author |
Cabré, Rosanna |
| author_facet |
Cabré, Rosanna Naudi, Alba Domínguez González, Mayelín Ayala, Victòria Jove, Mariona Mota-Martorell, Natalia Piñol Ripoll, Gerard Gil-Villar, Maria Pilar Rué, Montserrat Portero-Otin, Manuel Ferrer, Isidro (Ferrer Abizanda) Pamplona, Reinald |
| author_role |
author |
| author2 |
Naudi, Alba Domínguez González, Mayelín Ayala, Victòria Jove, Mariona Mota-Martorell, Natalia Piñol Ripoll, Gerard Gil-Villar, Maria Pilar Rué, Montserrat Portero-Otin, Manuel Ferrer, Isidro (Ferrer Abizanda) Pamplona, Reinald |
| author2_role |
author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Envelliment Lòbul frontal Metabolisme Aging Frontal lobe Metabolism |
| topic |
Envelliment Lòbul frontal Metabolisme Aging Frontal lobe Metabolism |
| description |
Human brain aging is the physiological process which underlies as cause of cognitive decline in the elderly and the main risk factor for neurodegenerative diseases such as Alzheimer's disease. Human neurons are functional throughout a healthy adult lifespan, yet the mechanisms that maintain function and protect against neurodegenerative processes during aging are unknown. Here we show that protein oxidative and glycoxidative damage significantly increases during human brain aging, with a breakpoint at 60 years old. This trajectory is coincident with a decrease in the content of the mitochondrial respiratory chain complex I to IV. We suggest that the deterioration in oxidative stress homeostasis during aging induces an adaptive response of stress resistance mechanisms based on the sustained expression of REST, and increased or decreased expression of Akt and mTOR, respectively, over the adult lifespan in order to preserve cell neural survival and function. |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2017 2019 2019 2019 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion |
| format |
article |
| status_str |
acceptedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/140516 |
| url |
https://hdl.handle.net/2445/140516 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Versió postprint del document publicat a: https://doi.org/10.1016/j.freeradbiomed.2016.12.010 Free Radical Biology and Medicine, 2017, vol. 103, p. 14-22 https://doi.org/10.1016/j.freeradbiomed.2016.12.010 |
| dc.rights.none.fl_str_mv |
cc-by-nc-nd (c) Elsevier B.V., 2017 http://creativecommons.org/licenses/by-nc-nd/3.0/es info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by-nc-nd (c) Elsevier B.V., 2017 http://creativecommons.org/licenses/by-nc-nd/3.0/es |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
9 p. application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier B.V. |
| publisher.none.fl_str_mv |
Elsevier B.V. |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Patologia i Terapèutica Experimental) reponame:Recercat. Dipósit de la Recerca de Catalunya instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| instname_str |
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| reponame_str |
Recercat. Dipósit de la Recerca de Catalunya |
| collection |
Recercat. Dipósit de la Recerca de Catalunya |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419933374349312 |
| score |
15,81155 |